Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) EPS (Basic) (2020 - 2026)

Treace Medical Concepts filings provide 6 years of EPS (Basic) readings, the most recent being -$0.14 for Q4 2025.

  • On a quarterly basis, EPS (Basic) fell 1300.0% to -$0.14 in Q4 2025 year-over-year; TTM through Dec 2025 was -$0.93, a 3.33% decrease, with the full-year FY2025 number at -$0.93, down 3.33% from a year prior.
  • EPS (Basic) hit -$0.14 in Q4 2025 for Treace Medical Concepts, up from -$0.26 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of -$0.01 in Q4 2024 to a low of -$0.34 in Q2 2024.
  • Median EPS (Basic) over the past 5 years was -$0.21 (2022), compared with a mean of -$0.19.
  • Biggest five-year swings in EPS (Basic): soared 90.0% in 2024 and later tumbled 1300.0% in 2025.
  • Treace Medical Concepts' EPS (Basic) stood at -$0.13 in 2021, then skyrocketed by 46.15% to -$0.07 in 2022, then crashed by 42.86% to -$0.1 in 2023, then soared by 90.0% to -$0.01 in 2024, then tumbled by 1300.0% to -$0.14 in 2025.
  • The last three reported values for EPS (Basic) were -$0.14 (Q4 2025), -$0.26 (Q3 2025), and -$0.28 (Q2 2025) per Business Quant data.